OFIX (Orthofix Medical Inc. Common Stock (DE))
Insider Trading Activity
Every open-market purchase and sale reported by OFIX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-23 | Juniper Investment Company, LLC | 10%+ Owner | Buy | — | — |
| 2026-09-22 | ALEXIS P MICHAS | 10%+ Owner | Sell | — | — |
| 2026-09-03 | Patrick Fisher | President, Global Limb Recon | Sell | — | — |
| 2026-08-20 | Patrick Fisher | President, Global Limb Recon | Sell | — | — |
| 2026-08-18 | ALEXIS P MICHAS | 10%+ Owner | Sell | — | — |
| 2026-06-22 | Aviva McPherron | Pres, Global Ops & Qual | Sell | — | — |
| 2026-06-12 | Michael E Paolucci | Director | A | — | — |
| 2026-06-12 | Charles R. Kummeth | Director | A | — | — |
| 2026-06-12 | JOHN B HENNEMAN III | Director | A | — | — |
| 2026-06-12 | Michael Finegan | Director | A | — | — |
| 2026-06-12 | VICKIE L CAPPS | Director | A | — | — |
| 2026-06-12 | Jason Hannon | Director | A | — | — |
| 2026-06-12 | Shweta Maniar | Director | A | — | — |
| 2026-06-12 | WAYNE BURRIS | Director | A | — | — |
| 2026-06-12 | Alan Lee Bazaar | Director | A | — | — |
| 2026-05-29 | John A. Bartholdson | 10%+ Owner | Sell | — | — |
| 2026-05-08 | JOHN B HENNEMAN III | Director | Buy | — | — |
| 2026-05-07 | ENGINE CAPITAL, L.P. | 10%+ Owner | Buy | — | — |
| 2026-04-20 | Jorge Andres Cedron | CLO | Sell | — | — |
| 2026-03-19 | Lucas Vitale | CP&BOO | Sell | — | — |
| 2026-03-10 | VICKIE L CAPPS | Director | Buy | — | — |
| 2026-03-06 | Lucas Vitale | CP&BOO | Sell | — | — |
| 2026-03-06 | Aviva McPherron | Pres, Global Ops & Qual | Sell | — | — |
| 2026-03-06 | Massimo Calafiore | President & CEO | Sell | — | — |
| 2026-03-06 | Jorge Andres Cedron | CLO | Sell | — | — |
| 2026-03-06 | Patrick Fisher | President, Global Limb Recon | Sell | — | — |
| 2026-03-06 | Julie Andrews | CFO | Sell | — | — |
| 2026-03-06 | MAX REINHARDT | President, Global Spine | Sell | — | — |
| 2026-03-05 | Massimo Calafiore | President & CEO | A | — | — |
| 2026-03-05 | Lucas Vitale | CP&BOO | A | — | — |
| 2026-03-05 | Aviva McPherron | Pres, Global Ops & Qual | A | — | — |
| 2026-03-05 | Patrick Fisher | President, Global Limb Recon | A | — | — |
| 2026-03-05 | Julie Andrews | CFO | A | — | — |
| 2026-03-05 | Jorge Andres Cedron | CLO | A | — | — |
| 2026-02-26 | Engine Investments II, LLC | 10%+ Owner | Buy | — | — |
| 2026-01-21 | Julie Andrews | CFO | Sell | — | — |
| 2026-01-13 | Massimo Calafiore | President & CEO | Sell | — | — |
| 2025-08-20 | Patrick Fisher | President, Global Orthopedics | Sell | — | — |
| 2025-07-07 | Engine Jet Capital, L.P. | 10%+ Owner | Buy | — | — |
| 2025-06-23 | Alan Lee Bazaar | Director | A | — | — |
| 2025-06-23 | JOHN B HENNEMAN III | Director | A | — | — |
| 2025-06-23 | Jason Hannon | Director | A | — | — |
| 2025-06-23 | Michael Finegan | Director | A | — | — |
| 2025-06-23 | WAYNE BURRIS | Director | A | — | — |
| 2025-06-23 | Michael E Paolucci | Director | A | — | — |
| 2025-06-23 | VICKIE L CAPPS | Director | A | — | — |
| 2025-06-23 | Aviva McPherron | Pres, Global Ops & Qual | Sell | — | — |
| 2025-06-23 | Shweta Maniar | Director | A | — | — |
| 2025-06-23 | Charles R. Kummeth | Director | A | — | — |
| 2025-06-13 | MAX REINHARDT | President, Global Spine | Sell | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 3,546,057 | — |
| — | 10%+ Owner | 3,544,807 | — |
| — | Director | 751,000 | — |
| — | President & CEO | 377,741 | — |
| — | 10%+ Owner | 375,946 | — |
| — | Executive Chairman | 346,827 | — |
| — | 10%+ Owner | 344,652 | — |
| — | 10%+ Owner | 344,652 | — |
| — | President & CEO | 320,136 | — |
| — | President, Global Orthopedics | 227,747 | — |
| — | Director | 205,966 | — |
| — | Director | 164,122 | — |
| — | CP&BOO | 160,449 | — |
| — | Director | 160,130 | — |
| — | CEO | 159,899 | — |
| — | President of Global Spine | 145,810 | — |
| — | Interim CEO | 112,803 | — |
| — | CFO | 107,679 | — |
| — | Director | 105,774 | — |
| — | Director | 102,727 | — |
| — | CFO | 99,670 | — |
| — | CFO | 88,746 | — |
| — | Director | 87,662 | — |
| — | Global President,North America | 86,693 | — |
| — | Director | 86,153 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the OFIX quote page; the site-wide leaderboard is on the insider transactions hub.